The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.
Highlights
The global Mycoplasma Testing market was valued at US$ 554.8 million in 2022 and is anticipated to reach US$ 1054.7 million by 2029, witnessing a CAGR of 11.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mycoplasma Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycoplasma Testing.
The Mycoplasma Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Mycoplasma Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycoplasma Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek
Segment by Type
PCR
ELSA
Enzymatic Methods
DNA Staining
Segment by Application
Pharmaceuticals
Food And Beverage Testing
Biotechnology, Biomedical Drugs
Environmental Test
Academic Research Institute
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Mycoplasma Testing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 ELSA
1.2.4 Enzymatic Methods
1.2.5 DNA Staining
1.3 麻豆原创 by Application
1.3.1 Global Mycoplasma Testing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceuticals
1.3.3 Food And Beverage Testing
1.3.4 Biotechnology, Biomedical Drugs
1.3.5 Environmental Test
1.3.6 Academic Research Institute
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Testing 麻豆原创 Perspective (2018-2029)
2.2 Mycoplasma Testing Growth Trends by Region
2.2.1 Global Mycoplasma Testing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Mycoplasma Testing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Mycoplasma Testing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Mycoplasma Testing 麻豆原创 Dynamics
2.3.1 Mycoplasma Testing Industry Trends
2.3.2 Mycoplasma Testing 麻豆原创 Drivers
2.3.3 Mycoplasma Testing 麻豆原创 Challenges
2.3.4 Mycoplasma Testing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Testing Players by Revenue
3.1.1 Global Top Mycoplasma Testing Players by Revenue (2018-2023)
3.1.2 Global Mycoplasma Testing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Mycoplasma Testing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mycoplasma Testing Revenue
3.4 Global Mycoplasma Testing 麻豆原创 Concentration Ratio
3.4.1 Global Mycoplasma Testing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Testing Revenue in 2022
3.5 Mycoplasma Testing Key Players Head office and Area Served
3.6 Key Players Mycoplasma Testing Product Solution and Service
3.7 Date of Enter into Mycoplasma Testing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycoplasma Testing Breakdown Data by Type
4.1 Global Mycoplasma Testing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Mycoplasma Testing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Mycoplasma Testing Breakdown Data by Application
5.1 Global Mycoplasma Testing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Mycoplasma Testing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Mycoplasma Testing 麻豆原创 Size (2018-2029)
6.2 North America Mycoplasma Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Mycoplasma Testing 麻豆原创 Size by Country (2018-2023)
6.4 North America Mycoplasma Testing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mycoplasma Testing 麻豆原创 Size (2018-2029)
7.2 Europe Mycoplasma Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Mycoplasma Testing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Mycoplasma Testing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mycoplasma Testing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Mycoplasma Testing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Mycoplasma Testing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Mycoplasma Testing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mycoplasma Testing 麻豆原创 Size (2018-2029)
9.2 Latin America Mycoplasma Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Mycoplasma Testing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Mycoplasma Testing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycoplasma Testing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Mycoplasma Testing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Mycoplasma Testing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Mycoplasma Testing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Detail
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Mycoplasma Testing Introduction
11.1.4 Charles River Laboratories International Revenue in Mycoplasma Testing Business (2018-2023)
11.1.5 Charles River Laboratories International Recent Development
11.2 Merck Kgaa
11.2.1 Merck Kgaa Company Detail
11.2.2 Merck Kgaa Business Overview
11.2.3 Merck Kgaa Mycoplasma Testing Introduction
11.2.4 Merck Kgaa Revenue in Mycoplasma Testing Business (2018-2023)
11.2.5 Merck Kgaa Recent Development
11.3 Lonza Group
11.3.1 Lonza Group Company Detail
11.3.2 Lonza Group Business Overview
11.3.3 Lonza Group Mycoplasma Testing Introduction
11.3.4 Lonza Group Revenue in Mycoplasma Testing Business (2018-2023)
11.3.5 Lonza Group Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Mycoplasma Testing Introduction
11.4.4 Roche Diagnostics Revenue in Mycoplasma Testing Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 SGS
11.5.1 SGS Company Detail
11.5.2 SGS Business Overview
11.5.3 SGS Mycoplasma Testing Introduction
11.5.4 SGS Revenue in Mycoplasma Testing Business (2018-2023)
11.5.5 SGS Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Mycoplasma Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Mycoplasma Testing Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 American Type Culture Collection
11.7.1 American Type Culture Collection Company Detail
11.7.2 American Type Culture Collection Business Overview
11.7.3 American Type Culture Collection Mycoplasma Testing Introduction
11.7.4 American Type Culture Collection Revenue in Mycoplasma Testing Business (2018-2023)
11.7.5 American Type Culture Collection Recent Development
11.8 Biounique Testing Laboratories
11.8.1 Biounique Testing Laboratories Company Detail
11.8.2 Biounique Testing Laboratories Business Overview
11.8.3 Biounique Testing Laboratories Mycoplasma Testing Introduction
11.8.4 Biounique Testing Laboratories Revenue in Mycoplasma Testing Business (2018-2023)
11.8.5 Biounique Testing Laboratories Recent Development
11.9 Invivogen
11.9.1 Invivogen Company Detail
11.9.2 Invivogen Business Overview
11.9.3 Invivogen Mycoplasma Testing Introduction
11.9.4 Invivogen Revenue in Mycoplasma Testing Business (2018-2023)
11.9.5 Invivogen Recent Development
11.10 Promocell
11.10.1 Promocell Company Detail
11.10.2 Promocell Business Overview
11.10.3 Promocell Mycoplasma Testing Introduction
11.10.4 Promocell Revenue in Mycoplasma Testing Business (2018-2023)
11.10.5 Promocell Recent Development
11.11 Biological Industries Israel Beit Haemek
11.11.1 Biological Industries Israel Beit Haemek Company Detail
11.11.2 Biological Industries Israel Beit Haemek Business Overview
11.11.3 Biological Industries Israel Beit Haemek Mycoplasma Testing Introduction
11.11.4 Biological Industries Israel Beit Haemek Revenue in Mycoplasma Testing Business (2018-2023)
11.11.5 Biological Industries Israel Beit Haemek Recent Development
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Detail
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec Mycoplasma Testing Introduction
11.12.4 Wuxi Apptec Revenue in Mycoplasma Testing Business (2018-2023)
11.12.5 Wuxi Apptec Recent Development
11.13 Norgen Biotek
11.13.1 Norgen Biotek Company Detail
11.13.2 Norgen Biotek Business Overview
11.13.3 Norgen Biotek Mycoplasma Testing Introduction
11.13.4 Norgen Biotek Revenue in Mycoplasma Testing Business (2018-2023)
11.13.5 Norgen Biotek Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek
听
听
*If Applicable.